Identification of Subgroups with Favorable Prognosis in Breast Cancer

References

• Fisher B, Redmond C, Dimitrov N V, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 1989; 320: 473–8
   PubMed Web of Science ®Google Scholar
• The Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 1989; 320: 491–6
   PubMed Web of Science ®Google Scholar
• Holleb A I. Breast cancer control. Cancer 1990; 66: 1309–12
   PubMed Web of Science ®Google Scholar
• McGuire W L. Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 1987; 10: 5–9
   PubMed Web of Science ®Google Scholar
• Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer—A study with long-term follow-up. Br J Cancer 1989; 60: 693–700
   PubMed Web of Science ®Google Scholar
• Histological typing of breast tumors. International histogical classification of tumors No. 2Second ed. WHO, Geneva 1981
   Google Scholar
• Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Musgrove E A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–5
   PubMed Web of Science ®Google Scholar
• Camplejohn R S, McArtney J C, Morris R W. Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4′,6′-diamino-2 phenylindole di-hydrochloride versus propidium iodide staining. Cytometry 1989; 10: 410–6
   PubMedGoogle Scholar
• Cox D R. Regression models and life-tables. J R Stat Soc 1972; 34: 187–220
   Google Scholar
• Pukkala E, Rimpelä A, Läärä E. Cancer in Finland5th Edition. Helsinki 1990
   Google Scholar
• Ewertz M, Carstensen B. Trends in breast cancer incidence and mortality in Denmark, 1943–1982. Int J Cancer 1988; 41: 46–51
   PubMed Web of Science ®Google Scholar
• Pollack E S, Horm J W. Trends in cancer incidence and mortality in the United States, 1969–76. JNCI 1980; 64: 1091–103
   PubMed Web of Science ®Google Scholar
• Joensuu H, Toikkanen S. Comparison of breast carcinomas diagnosed in the 1980's with those diagnosed in the 1940's to 1960's. Br Med J 1991; 303: 155–88
   PubMed Web of Science ®Google Scholar
• Toikkanen S, Joensuu H. Prognostic factors and long-term survival in breast cancer in a defined urban population. APMIS 1990; 98: 1005–14
   PubMed Web of Science ®Google Scholar
• Fornander T, Rutqvist L E, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989; 1: 117–20
   PubMed Web of Science ®Google Scholar
• Curtis R E, Boice J D, Moloney W C, Ries L G, Flannery J T. Leukemia following chemotherapy for breast cancer. Cancer Res 1990; 50: 2741–6
   PubMed Web of Science ®Google Scholar
• Lewis W E. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Cancer 1990; 65: 2315–20
   PubMed Web of Science ®Google Scholar
• van der Linden J C, Lindeman J, Baak J PA, Meijer C JLM, Herman C J. The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 1989; 10: 56–61
   PubMedGoogle Scholar
• Hedley D W, Rugg C A, Ng A BP, Taylor I W. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 1984; 44: 5395–8
   PubMed Web of Science ®Google Scholar
• Uyterlinde A M, Baak J PA, Schipper N W, Peterse H, Matze E, Meijer C JL. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast cancer patients with long follow-up. Int J Cancer 1990; 45: 1–7
   PubMed Web of Science ®Google Scholar
• Sigurdsson H, Baldetorp B, Borg Å, et al. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990; 322: 1045–53
   PubMed Web of Science ®Google Scholar
• Kallioniemi O-P, Blanco G, Alavaikko M, et al. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987; 56: 637–42
   PubMed Web of Science ®Google Scholar
• Clark G M, Dressier L G, Owens M A, Pounds G, Oldaker T, McGuire W L. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989; 320: 627–33
   PubMed Web of Science ®Google Scholar
• Stål O, Wingren S, Carstensen J, et al. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. Eur J Cancer Clin Oncol 1989; 25: 301–9
   PubMedGoogle Scholar
• Hedley D W, Rugg C A, Gelber R D. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987; 47: 4729–35
   PubMed Web of Science ®Google Scholar
• Ewers S-B, Baldetorp B, Killander D, Långström E. Flow cytometry DNA ploidy and number of cell populations in the primary breast cancer and their correlation to the prognosis. Acta Oncol 1989; 28: 913–8
   PubMed Web of Science ®Google Scholar
• Beerman H, Kluin Ph M, Hermans J, van de Velde C JH, Cornelisse C J. Prognostic significance of DNA-ploidy in a series of 690 breast cancer patients. Int J Cancer 1990; 45: 34–9
   PubMed Web of Science ®Google Scholar
• Keyhani-Rofagha S, O'Toole R V, Farrar W B, Sicle-Santanello B, DeCenzo J, Young D. Is DNA ploidy and independent prognostic factor in infiltrative node-negative breast adenocarcinoma?. Cancer 1990; 65: 1577–82
   PubMed Web of Science ®Google Scholar
• O'Reilly S M, Camplejohn R S, Barnes D M, Mills R R, Rubens R D, Richards M A. Node-negative breast cancer: Prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 1990; 8: 2040–6
   PubMed Web of Science ®Google Scholar
• Kute T E, Muss H B, Cooper M R, et al. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer 1990; 66: 1810–6
   PubMed Web of Science ®Google Scholar
• Winchester D J, Duda R B, August C Z, et al. The importance of DNA flow cytometry in node-negative breast cancer. Arch Surg 1990; 125: 886–9
   PubMed Web of Science ®Google Scholar
• Dowle C S, Owainati A, Robins A, et al. Prognostic significance of the DNA content of human breast cancer. Br J Surg 1987; 74: 133–6
   PubMed Web of Science ®Google Scholar